Health Sciences: Dr. in Medicine and Surgery
Date of admittance: 23/07/2015
Admission Speech: Panacea encadenada. La farmacología alemana bajo el yugo de la esvástica
He began his teaching and research career in the Department of Cell Biology of the Faculty of Medicine of the UCM, in the field of neurohistology, and subsequently, since 1992 in Juste, SAQF, as Medical Director, and since 1996 in the Department of Pharmacology. from the University of Alcalá (UAH) as an honorary research professor, working mainly in the field of neuropsychopharmacology. Currently, he is a member of the Research Institute Hospital 12 de Octubre in Madrid (2013) and the Portucalense Institute of Neuropsychology (INPP) of the Portulalense University Infante Dom Henrique in Oporto, Portugal (2015), and expert evaluator of ANECA, in its ACREDITA Valuation Programs for the Renewal of the Initial Accreditation of the Official Titles (2014) and HOMOLOGA of Homologation of Foreign Titles (2015).
In 2011 he joined the Camilo José Cela University (UCJC) as Accredited Professor of Pharmacology, in 2013 he obtained the accreditation of the ANECA as Professor of University and in 2014 positive resolution of the Council of Universities granting the exemption for accreditation to the Body of University Professors. He is currently Director of the International Doctoral School of the UCJC, Director of the PhD Program in Health Sciences, Sub-Director of the Chair of Genomic Medicine and Deputy to the Counseling-Directorate of Teaching Staff.
He has participated as a visiting professor or as a director in more than 90 postgraduate and doctoral courses of different academic centers, including the coordination of the XVI, XVII and XVIII Summer Courses of the University of Alcalá (Department of Pharmacology) between 1999-2002 . In the last 5 years he has been part of the teaching team of the National Continuing Education Plan of the General Council of Official Associations of Pharmacists of Spain, accredited by the Continuing Education Commission of the National Health System.
He has directed 6 Doctoral Theses and is director of another 7 in the implementation phase, and has participated in numerous research projects funded in competitive calls (including FIS, PNSD). He currently has a positive evaluation of the CNEAI of two sexenios of investigation and has acted as evaluator of research projects for the UEFISCDI (Government of Romania) and the HRB (Republic of Ireland).
He is the editor of 12 treatises (among which we should mention the “History of Psychopharmacology”, in three volumes, edited by Editorial Médica Panamericana – recently published in English by NPP Books, Arlington, USA-, and “Neurobiology of Depression”, by the prestigious series Frontiers in Neuroscience, 2012), author of 12 books and 190 chapters of books related to psychopharmacology and other fields of pharmacology and neuroscience (30 of them in international editions). It has 125 publications in international journals with impact factor (JCR-ISI), 24 of them located in the first tertile of its section, and more than 190 in journals in the Spanish and Latin American context, with an H = 24 Index and a Factor of Total Impact of 172.35 (September 2015). He is a member of 26 editorial committees, highlighting the European Journal of Pharmacology and Frontiers in Psychopharmacology and has acted as reviewer / evaluator of 41 international journals in his specialty with JCR relative quality index. He is currently Co-Editor-in-Chief of Clinical & Experimental Pharmacology (Henderson, USA) and Editor-in-Chief of the Journal of Clinical Medicine Research Updates (Karachi, Pakistan).
He has been part of the Organizing Committee of 14 Congresses in the area of pharmacology and psychiatry and has given 28 presentations at conferences and more than 150 scientific papers at international and national conferences. He has been or is a member of a number of different scientific societies, including the CINP (Collegium Internationale Neuro-Psychopharmacologicum), ENA (European Neuroscience Association), IBRO (International Brain Research Organization) or CSA (Cervantes Society of America), as well as networks international organizations, such as the International Network for the History of Neuropsychopharmacology (INHN). He is a Partner Founder and Vice President of the Scientific Association of Criminology of Castilla – La Mancha (ACCCM).
He has various awards and recognitions to his research, such as the Extraordinary Doctorate Award of the Complutense University (1994), the ATLAS Award for Neuroscience and Aging Saludable (2014) and the Prize for Research at the Camilo José Cela University 2013 / 14.The main lines of research have been the neurobiological bases of drug addiction and dual pathology, the drug interactions of psychotropic drugs, the neurobiology of the aggressiveness, bibliometric techniques applied to the neuropsychiatric disciplines, and more recently combination treatments in patients with depressive and psychotic disorders and the history of psychopharmacology and neurosciences (the use of psychotropic agents in literary texts of the Golden Age, psychopharmacological abuses committed during the III Reich, etc.).